Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 4 percent year over year increase in its fiscal second quarter revenues on record performance in its diagnostics and life science segments.

For the three months ended March 31, the Cincinnati-based company's revenues rose to $56.5 million from $54.1 million a year ago, surpassing analysts' consensus estimate of $55.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.